To include your compound in the COVID-19 Resource Center, submit it here.

RSR13: Phase II

Preliminary data from the first 30 patients with stage IIIA and IIIB NSCLC

Read the full 137 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE